DBS Group Holdings Ltd (BKK:DBS19)

Market Cap	3.40T
Revenue (ttm)	551.79B
Net Income (ttm)	281.69B
Shares Out	n/a
EPS (ttm)	99.19
PE Ratio	12.08
Forward PE	12.38
Dividend	0.46 (3.80%)
Ex-Dividend Date	May 16, 2025

Volume	1,197
Average Volume	44,308
Open	12.20
Previous Close	12.10
Day's Range	12.10 - 12.20
52-Week Range	9.30 - 12.60
Beta	n/a
RSI	57.91
Earnings Date	Aug 7, 2025

About Regulus Therapeutics

DBS Group Holdings Ltd provides commercial banking and financial services in Singapore, Hong Kong, rest of Greater China, South and Southeast Asia, and internationally. It operates through Consumer Banking/ Wealth Management; Institutional Banking; and Global Financial Markets segments. The Consumer Banking/Wealth Management segment offers banking and related financial services, including current and savings accounts, fixed deposits, loans and home finance, cards, payments, investment, and insurance products for individual customers. The Instit...

• Industry: Commercial Banks
• Founded: 1968
• Employees: 41,000
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: DBS19

Financial Performance

In 2024, DBS Group Holdings's revenue was 21.68 billion, an increase of 10.85% compared to the previous year's 19.55 billion. Earnings were 11.21 billion, an increase of 12.30%.